Register for upcoming (live) or recorded webinars, choose by topic, or search by keyword to find webinars of interest.


Biosimilars, generally, are larger molecular drugs, derived from, or made by an organism, in which, the patent for the original drug has expired, and subsquently, a similar molecule can be designed and marketed. There are a wide range of topics covered in our webinars under the term, biosimilars – from testing immunogenicity of biosimilar drugs and testing biosimilars in clinical trials, to conducting safety assessments of biosimilars and meeting FDA guidelines.